Coronary Artery Disease Clinical Trials in Phoenix, Arizona

5 studies are recruiting for coronary artery disease in Phoenix, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Product Surveillance Registry

   The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

   Stage

   Not phased

   Ages

   Any age

   Site

   Research site, Phoenix, Arizona

   Locations

   401 in total

   Run by

   Medtronic

   See if you can join NCT01524276 on ClinicalTrials.gov

2. Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

   This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasibility of the percutaneous endovascular catheter-facilitated intramyocardial delivery of XC001 in patients with RA due to obstructive CAD. Pa…

   Stage

   Phase 2

   Ages

   18 to 85

   Site

   Mayo Clinic, Phoenix, Arizona

   Locations

   14 in total

   Run by

   XyloCor Therapeutics, Inc.

   See if you can join NCT07048808 on ClinicalTrials.gov

3. Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

   Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiate…

   Stage

   Not phased

   Ages

   Any age

   Site

   Banner Samaritan Health Center, Phoenix, Arizona

   Locations

   48 in total

   Run by

   Minneapolis Heart Institute Foundation

   See if you can join NCT02061436 on ClinicalTrials.gov

4. ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

   The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Banner University Medical Center, Phoenix, Arizona

   Locations

   19 in total

   Run by

   Emory University

   See if you can join NCT07559903 on ClinicalTrials.gov

5. Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

   Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…

   Stage

   Not phased

   Ages

   Any age

   Site

   Arizona Cardiovascular Research, Phoenix, Arizona

   Locations

   72 in total

   Run by

   University of British Columbia

   See if you can join NCT04634240 on ClinicalTrials.gov